A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy
Clinical trial NCT07010263 · RECRUITING
Trial details
- NCT number
- NCT07010263
- Sponsor
- Akeso
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-13
- Primary completion
- 2028-12-31
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.